NCT06949059View on ClinicalTrials.gov

Intravenous Hydromorphone for the Treatment of Acute Pain

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Chest Pain
Interventions
DRUG

Hydromorphone

Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time.

Trial Locations (1)

210008

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
collaborator

Yichang Humanwell Pharmaceutical Co., Ltd., China

INDUSTRY

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER